<--- Back to Details
First PageDocument Content
Biology / Interferon beta-1a / Pfizer / Anatomy / Interferon beta-1b / Autoimmune diseases / Neurological disorders / Therapies under investigation for multiple sclerosis / Treatment of multiple sclerosis / Multiple sclerosis / Cytokines / Immune system
Date: 2013-12-04 21:15:58
Biology
Interferon beta-1a
Pfizer
Anatomy
Interferon beta-1b
Autoimmune diseases
Neurological disorders
Therapies under investigation for multiple sclerosis
Treatment of multiple sclerosis
Multiple sclerosis
Cytokines
Immune system

Oral Oncology Referral Form

Add to Reading List

Source URL: www.nhhealthyfamilies.com

Download Document from Source Website

File Size: 56,65 KB

Share Document on Facebook

Similar Documents

Health / Multiple Sclerosis Trust / Interferon beta-1a / Treatment of multiple sclerosis / Therapies under investigation for multiple sclerosis / Multiple sclerosis / Immune system / Immunology

Quarterly newsletter of the MS Trust Open Door MayAlso in this issue

DocID: 1aIBR - View Document

Medicine / Anatomy / Neurological disorders / Swank diet / Neurology / Treatment of multiple sclerosis / Therapies under investigation for multiple sclerosis / Multiple sclerosis / Autoimmune diseases / Health

Microsoft Word - stc_information_pack

DocID: 13Q2D - View Document

Immune system / MS Australia / Immunotherapy / Dimethyl fumarate / Therapies under investigation for multiple sclerosis / Treatment of multiple sclerosis / Multiple sclerosis / Medicine / Immunology

Treatments for MS: TECFIDERA® (dimethyl fumarate) There are currently nine disease-modifying therapies approved for people with MS in Australia. These therapies, called immunotherapies, work to reduce disease activity i

DocID: 10jxE - View Document

Anatomy / Fingolimod / Sphingosine-1-phosphate / MS Australia / Remyelination / Therapies under investigation for multiple sclerosis / Treatment of multiple sclerosis / Multiple sclerosis / Immunology / Immune system

Treatments for MS: Gilenya ® (fingolimod) There are currently several disease-modifying therapies approved for people with MS in

DocID: Xydz - View Document

Organic chemistry / Immunosuppressants / Anilides / Organofluorides / Nitriles / Teriflunomide / MS Australia / Immunotherapy / Therapies under investigation for multiple sclerosis / Multiple sclerosis / Medicine / Immunology

Treatments for MS: Aubagio ® (Teriflunomide) There are currently nine disease-modifying therapies approved for people with MS in

DocID: Wu9v - View Document